Pancreatic endocrine tumors (PETs) have long fascinated clinicians and investigators
despite their relative rarity. Their clinical presentation varies depending on whether the …

Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that
originate from endocrine glands such as the pituitary, the parathyroids, and the …

Background Insulinomas are rare tumours. Their clinical presentation, localization
techniques and operative management were reviewed. Methods An electronic search of the …

BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is one of the most common cancer-
related causes of death worldwide. Due to very poor 5-year-survival new therapeutic …

Gastroenteropancreatic neuroendocrine neoplasms are heterogeneous in their clinical
behavior and require therapies specially tailored according to staging, grading, origin and …

This review describes the recent advances in the molecular events involved in pancreatic
cancer initiation, progression, and metastasis. Additionally, the importance of deregulated …

Hepatocellular carcinoma (HCC) is one of the most common cancer-related causes of death
worldwide. Due to very poor 5-year-survival new therapeutic approaches are mandatory …

Background Chemotherapy is well-established in the treatment of patients with well-
differentiated neuroendocrine tumours (NETs) arising from the pancreas (pNETs); however …

The epidermal growth factor receptor (EGFR) plays an important role in the pathogenesis of
many tumors. To analyze the expression of EGFR and activated EGFR in well-differentiated …

Gastrointestinal neuroendocrine tumours (NET) represent a heterogeneous tumour entity.
The anti-neoplastic therapy of advanced NET disease is still unsatisfactory and innovative …